WinstonWınston
Back
Alcon AG logo

Alcon AG

0A0D.IL
Medical - Specialties · Healthcare
Price
CHF 58.18
-1.23 (-2.07%)
Market Cap
CHF 28.36B
Exchange
International Order Book
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Winston Score History

The full picture

Alcon is the world's largest eye care device company. It makes surgical equipment and supplies used by eye doctors to perform cataract, glaucoma, and retinal surgeries. It also sells contact lenses and lens care products directly to consumers and eye care professionals.

Alcon earns revenue through two main segments: surgical products (instruments, implantable lenses, and consumables) and vision care (contact lenses and solutions). The company is headquartered in Switzerland and sells its products in roughly 140 countries. Its scale, deep relationships with surgeons, and large installed base of surgical equipment create meaningful switching costs. Key growth drivers include aging global populations needing more eye surgeries and the adoption of premium intraocular lenses, though the company faces ongoing competition from other medical device makers and pricing pressure in certain markets.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
N/A
no trend
Data not available
Profit after running costs
Operating Margin
N/A
no trend
Data not available
Return on the money invested
ROCE
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
no trend
Data not available
Profit growth
EPS YoY
N/A
no trend
Data not available
How steady the profit is
EPS Consistency
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
no trend
Data not available
Spare cash per sale
FCF Margin
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
no trend
Data not available
Covers its interest
Interest Cover
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
56.6x
no trend
Expensive — P/E 56.6

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.48%
no trend
Small dividend — 0.48% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial